Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of January 2026, with a report date of January 15, 2026. The filing primarily addresses changes in the Company's senior management team.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance updates and does not contain financial performance data.
Material Changes
- Resignation of CFO: Mr. Yaron Eldad, Chief Financial Officer, resigned effective March 31, 2026. The resignation is attributed to personal reasons and is not related to any disagreement with the Company regarding operations, policies, or practices.
- Succession Plan: Ms. Polina Ravzin, currently VP Finance, will assume the responsibilities of the CFO. Ms. Ravzin has served as VP Finance since 2022 and previously held controller and assistant CFO roles at DSIT Solutions Ltd. and Acorn Energy Inc.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or specific risk factors. Management commentary is limited to expressing gratitude to Mr. Eldad for his contributions and wishing Ms. Ravzin success in her new role. The document notes that this Form 6-K is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
Key Facts for Investor Verification
- Verify the effective date of the CFO transition (March 31, 2026) and any interim financial reporting implications.
- Confirm Ms. Polina Ravzin's official appointment as CFO in subsequent filings or press releases.
- Review the Company's upcoming Form 20-F for the next available financial data, as this 6-K contains no financial metrics.